Antibiotice S.A. (BVB:ATB)
2.310
-0.040 (-1.70%)
At close: Jan 30, 2026
Antibiotice Market Cap
Antibiotice has a market cap or net worth of 1.55 billion as of January 30, 2026. Its market cap has decreased by -9.06% in one year.
Market Cap
1.55B
Enterprise Value
1.80B
Revenue
648.96M
Ranking
n/a
PE Ratio
27.26
Stock Price
2.31
Market Cap Chart
Since December 20, 2004, Antibiotice's market cap has increased from 202.01M to 1.55B, an increase of 667.70%. That is a compound annual growth rate of 10.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.55B | -5.71% |
| Dec 30, 2025 | 1.64B | -4.30% |
| Dec 30, 2024 | 1.72B | 83.51% |
| Dec 29, 2023 | 936.52M | 146.47% |
| Dec 30, 2022 | 379.98M | -6.60% |
| Dec 30, 2021 | 406.83M | 24.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquila Part Prod Com | 2.12B |
| Fondul Proprietatea | 2.01B |
| Rompetrol Rafinare | 1.92B |
| Cris-Tim Family Holding | 1.73B |
| Infinity Capital Investments | 1.61B |
| Aerostar | 1.59B |
| Teraplast | 1.50B |
| Sphera Franchise Group | 1.47B |